Citation Impact
Citing Papers
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
2004
The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis
2012
Epidermal T Cells and Wound Healing
2010
Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy
2005
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
2013
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
The polarization of immune cells in the tumour environment by TGFβ
2010
Selective PDE inhibitors as novel treatments for respiratory diseases
2012
Hepatocellular carcinoma
2016 Standout
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment
2017
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
γδ T cells: functional plasticity and heterogeneity
2002
Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy
2016
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
2011 Standout
Brucellosis
2005 Standout
Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors
2005
Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis
2008
On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease
1999
The Immune System
2000
Understanding the pathogenesis of allergic asthma using mouse models
2001
Environmental Exposure to Endotoxin and Its Relation to Asthma in School-Age Children
2002 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Role of Epithelial Cells in Idiopathic Pulmonary Fibrosis: From Innocent Targets to Serial Killers
2006
Thymic self-reactivity selects natural interleukin 17–producing T cells that can regulate peripheral inflammation
2009
The development of allergic inflammation
2008 StandoutNature
Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors
2009
Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
2011
Immunity, Inflammation, and Cancer
2010 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Inflammation and cancer: back to Virchow?
2001 Standout
Programmed Cell Senescence during Mammalian Embryonic Development
2013 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
EMT: 2016
2016 Standout
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
γδ T cells: an important source of IL-17
2008
To respond or not to respond: T cells in allergic asthma
2003
Cytokine-secreting tumor cell vaccines
2000
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
2002 StandoutNature
TRIM28 prevents autoinflammatory T cell development in vivo
2012 StandoutNobel
T Cell Immunoglobulin Mucin-3 Crystal Structure Reveals a Galectin-9-Independent Ligand-Binding Surface
2007 StandoutNobel
Autoreactivity by design: innate B and T lymphocytes
2001
Idiopathic pulmonary fibrosis
2011 Standout
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
2010 StandoutNature
Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family
2001
Polymyositis and dermatomyositis
2003 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Exploring the full spectrum of macrophage activation
2008 Standout
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
2015
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
2013 StandoutNobel
Design of multifunctional non-viral gene vectors to overcome physiological barriers: Dilemmas and strategies
2011
β-Arrestin-2 regulates the development of allergic asthma
2003 StandoutNobel
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
2014 Standout
The role of T lymphocytes in the pathogenesis of asthma
2003
Pirfenidone Modulates Airway Responsiveness, Inflammation, and Remodeling after Repeated Challenge
2006
Activin receptor‐like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes
2014
Activin receptor‐like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes
2013
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity.
2001
An Autoreactive γδ TCR Derived from a Polymyositis Lesion
2002
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus
2004 StandoutNobel
Immune Response Induced by Airway Sensitization after Influenza A Virus Infection Depends on Timing of Antigen Exposure in Mice
2001
Advances in skin grafting and treatment of cutaneous wounds
2014 StandoutScience
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Vγ9Vδ2 T Cells Impair Intracellular Multiplication ofBrucella suisin Autologous Monocytes Through Soluble Factor Release and Contact-Dependent Cytotoxic Effect
2000
Nonviral Vectors for Gene Delivery
2008 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Intraepithelial CD8+tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
2005 Standout
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Implications of B7-H1 Expression in Clear Cell Carcinoma of the Kidney for Prognostication and Therapy
2007
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
T Cell Trafficking in Allergic Asthma: The Ins and Outs
2008
Dendritic cell maturation by innate lymphocytes
2005 StandoutNobel
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Targeting the TGFβ pathway for cancer therapy
2014
β-Arrestin-2 regulates the development of allergic asthma
2003 StandoutNobel
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
Influenza Virus–induced Dendritic Cell Maturation Is Associated with the Induction of Strong T Cell Immunity to a Coadministered, Normally Nonimmunogenic Protein
2003 StandoutNobel
TGF-β blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner
2015
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
γδ Cells: A Right Time and a Right Place for a Conserved Third Way of Protection
2000
A Population of Murine γδ T Cells That Recognize an Inducible MHC Class Ib Molecule
2000 Science
Transforming Growth Factor-β as a Therapeutic Target in Hepatocellular Carcinoma
2014
Works of Michael Lahn being referenced
Early preferential stimulation of gamma delta T cells by TNF-alpha.
1998
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
2018
Role of gammadelta T cells in protecting normal airway function
2000
Subset-specific, uniform activation among Vγ6/Vδ1+ γδ T cells elicited by inflammation
2003
Trimodal Glioblastoma Treatment Consisting of Concurrent Radiotherapy, Temozolomide, and the Novel TGF-β Receptor I Kinase Inhibitor LY2109761
2011
Negative regulation of airway responsiveness that is dependent on γδ T cells and independent of αβ T cells
1999
Induction of tumor-specific cytotoxic T lymphocytes by immunization with autologous tumor cells and interleukin-2 gene transfected fibroblasts
1997
Tumor Survivin Is Downregulated by the Antisense Oligonucleotide LY2181308: A Proof-of-Concept, First-in-Human Dose Study
2010
Pro-Inflammatory and T Cell Inhibitory Cytokines Are Secreted at High Levels in Tumor Cell Cultures of Human Renal Cell Carcinoma
1999
Antisense therapy directed to protein kinase C-alpha (affinitak, LY900003/ISIS 3521): Potential role in breast cancer
2003
A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer
1997
Inhibiting TGF-β signaling in hepatocellular carcinoma
2010
Early Preferential Stimulation of γδ T Cells by TNF-α
1998
Tumor Necrosis Factor- α Negatively Regulates Airway Hyperresponsiveness through γδ T Cells
2001
Inhibition of Phosphodiesterase 4 Attenuates Airway Hyperresponsiveness and Airway Inflammation in a Model of Secondary Allergen Challenge
2001
First human dose (FHD) study of the oral transforming growth factor-beta receptor I kinase inhibitor LY2157299 in patients with treatment-refractory malignant glioma.
2011
Distribution and leukocyte contacts of γδ T cells in the lung
2005
Different Potentials of γδ T Cell Subsets in Regulating Airway Responsiveness: Vγ1+ Cells, but Not Vγ4+ Cells, Promote Airway Hyperreactivity, Th2 Cytokines, and Airway Inflammation
2004
A phase 2 study of a novel transforming growth factor-beta (TGF-β1) receptor I kinase inhibitor, LY2157299 monohydrate (LY), in patients with advanced hepatocellular carcinoma (HCC).
2014
Immunoregulatory Functions of γδ T Cells
1998
Vγ4+ γδ T Cells Regulate Airway Hyperreactivity to Methacholine in Ovalbumin-Sensitized and Challenged Mice
2003
Transfer of the Enhancing Effect of Respiratory Syncytial Virus Infection on Subsequent Allergic Airway Sensitization by T Lymphocytes
1999
First human dose escalation study in patients with metastatic malignancies to determine safety and pharmacokinetics of LY2157299, a small molecule inhibitor of the transforming growth factor-beta receptor I kinase
2008
Phase III Study of Gemcitabine and Cisplatin With or Without Aprinocarsen, a Protein Kinase C-Alpha Antisense Oligonucleotide, in Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2006
Evidence that the same gamma delta T cells respond during infection-induced and autoimmune inflammation.
1997
Randomized dose comparison phase II study of the oral transforming growth factor-beta (TGF-ß) receptor I kinase inhibitor LY2157299 monohydrate (LY) in patients with advanced hepatocellular carcinoma (HCC).
2013